AlphaCrest Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,982
| Closed | -$232K | – | 1196 |
|
|
2022
Q3 | $232K | Sell |
4,982
-5,253
| -51% | -$245K | 0.01% | 1211 |
|
|
2022
Q2 | $584K | Buy |
+10,235
| New | +$584K | 0.03% | 898 |
|
|
2022
Q1 | – | Sell |
-4,600
| Closed | -$241K | – | 1436 |
|
|
2021
Q4 | $241K | Buy |
+4,600
| New | +$241K | 0.01% | 1301 |
|
|
2021
Q3 | – | Sell |
-5,200
| Closed | -$212K | – | 1404 |
|
|
2021
Q2 | $212K | Buy |
+5,200
| New | +$212K | 0.01% | 1186 |
|
|
2021
Q1 | – | Sell |
-8,300
| Closed | -$264K | – | 1333 |
|
|
2020
Q4 | $264K | Buy |
+8,300
| New | +$264K | 0.02% | 963 |
|